Coherus BioSciences (CHRS) – Upgrades
-
UBS Upgrades Coherus Biosciences (CHRS) to Buy, 'Underappreciated growth narrative, cheap valuation'
-
UPDATE: Hot Topic (HOTT) Shares Rise as B. Riley Upgrades Amid M&A Speculation
-
-
-
-
-
-
Back to CHRS Stock Lookup